In vivo evaluation of adeno-associated virus gene transfer in airways of mice with acute or chronic respiratory infection

Human Gene Therapy

Volumn 25, Issue 11, 2014, Pages 966-976

  Myint, Melissa ^a   Limberis, Maria P ^b   Bell, Peter ^b   Somanathan, Suryanarayan ^b   Haczku, Angela ^b   Wilson, James M ^b   Diamond, Scott L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORDETELLA BRONCHISEPTICA; COLONY FORMING UNIT; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NOSE INFECTION; PSEUDOMONAS AERUGINOSA; REPORTER GENE; RESPIRATORY TRACT INFECTION; ACUTE DISEASE; ANIMAL; BORDETELLOSIS; C57BL MOUSE; CHRONIC DISEASE; COMPLICATION; CYSTIC FIBROSIS; DEPENDOPARVOVIRUS; GENETIC TRANSDUCTION; GENETICS; HUMAN; MICROBIOLOGY; PSEUDOMONAS INFECTION;

ACUTE DISEASE; ANIMALS; BORDETELLA INFECTIONS; CHRONIC DISEASE; CYSTIC FIBROSIS; DEPENDOVIRUS; HUMANS; MALE; MICE, INBRED C57BL; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; TRANSDUCTION, GENETIC;

EID: 84910633195     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2014.002     Document Type: Article

References (30)

1. Bell, C.L., et al. (2011). The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J. Clin. Invest. 121, 2427-2435.
2. Birault, V., Solari, R., Hanrahan, J., and Thomas, D.Y. (2013). Correctors of the basic trafficking defect of the mutant F508del-CFTR that causes cystic fibrosis. Curr. Opin. Chem. Biol. 17, 353-360.
3. Bobadilla, J.L., Macek, M., Fine, J.P., and Farrell, P.M. (2002). Cystic fibrosis: A worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum. Mutat. 19, 575-606.
4. Botas, C., et al. (1998). Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc. Natl. Acad. Sci. USA 95, 11869-11874.
5. Breous, E., Somanathan, S., Bell, P., and Wilson, J.M. (2011). Inflammation promotes the loss of adeno-Associated virusmediated transgene expression in mouse liver. Gastroenterology 141, 348-357, 357. e1-3.
6. Chattoraj, S.S., et al. (2010). Pseudomonas aeruginosa alginate promotes Burkholderia cenocepacia persistence in cystic fibrosis transmembrane conductance regulator knockout mice. Infect. Immun. 78, 984-993.
7. Chen, Y., et al. (2003). Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine/ autocrine loop. J. Biol. Chem. 278, 17036-17043.
8. Cheng, O.Z., and Palaniyar, N. (2013). NET balancing: A problem in inflammatory lung diseases. Front. Immunol. 4, 1.
9. Cystic Fibrosis Foundation (2012). Cystic Fibrosis Foundation-Patient Registry Annual Data Report. Bethesda, MD.
10. Davis, P.B., Drumm, M., and Konstan, M.W. (1996). Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154, 1229-1256.
11. Ferrari, S., Geddes, D.M., and Alton, E.W.F.W. (2002). Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv. Drug Deliv. Rev. 54, 1373-1393.
12. Giannoni, E., et al. (2006). Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am. J. Respir. Cell Mol. Biol. 34, 704-710.
13. Govan, J.R., and Deretic, V. (1996). Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60, 539-574.
14. Gueirard, P., et al. (2003). Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract. Infect. Immun. 71, 4137-4143.
15. Hoffmann, N., et al. (2005). Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun. 73, 2504-2514.
16. Irie, Y., and Yuk, M.H. (2007). In vivo colonization profile study of Bordetella bronchiseptica in the nasal cavity. FEMS Microbiol. Lett. 275, 191-198.
17. Lee, T.W.R., Matthews, D.a., and Blair, G.E. (2005). Novel molecular approaches to cystic fibrosis gene therapy. Biochem. J. 387, 1-15.
18. Makam, M., et al. (2009). Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc. Natl. Acad. Sci. USA 106, 5779-5783.
19. Martino, A.T., et al. (2009). Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: Implications for antigen presentation and immunotoxicity. PLoS One 4, e6376.
20. Moss, R.B., et al. (2004). Repeated adeno-Associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125, 509-521.
21. Moss, R.B., et al. (2005). Randomized, double-blind, placebocontrolled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Pediatr. Pulmonol. 39, 209-218.
22. Moss, R.B., et al. (2007). Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: A randomized placebo-controlled phase 2B trial. Hum. Gene Ther. 18, 726-732.
23. Oakland, M., Sinn, P.L., and McCray, P.B. (2012). Advances in cell and gene-based therapies for cystic fibrosis lung disease. Mol. Ther. 20, 1108-1115.
24. Pezzulo A.A. et al. 2012 Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung Nature 487 109-113.
25. Postle, A.D., et al. (1999). Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis underlying the relative ineffectiveness of the cellular inflammatory response in killing invading bacteria in. Am. J. Respir. Cell Mol. Biol. 20, 90-98.
26. Rieger, R., and Kipps, T.J. (2003). CpG oligodeoxynucleotides enhance the capacity of adenovirus-mediated CD154 gene transfer to generate effective B-cell lymphoma vaccines. Cancer Res. 63, 4128-4135.
27. Salucci, V., et al. (2006). CD8 + T-cell tolerance can be broken by an adenoviral vaccine while CD4 + T-cell tolerance is broken by additional co-Administration of a Toll-like receptor ligand. Scand. J. Immunol. 63, 35-41.
28. Sinn, P.L., Anthony, R.M., and McCray, P.B. (2011). Genetic therapies for cystic fibrosis lung disease. Hum. Mol. Genet. 20(R1), R79-R86.
29. Van Heeckeren, A.M., and Schluchter, M.D. (2002). Murine models of chronic Pseudomonas aeruginosa lung infection. Lab. Anim. 36, 291-312.
30. Wu, H., et al. (2000). Detection of N-Acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa. Microbiology 146, 2481-2493.